JP2004506722A5 - - Google Patents

Download PDF

Info

Publication number
JP2004506722A5
JP2004506722A5 JP2002521433A JP2002521433A JP2004506722A5 JP 2004506722 A5 JP2004506722 A5 JP 2004506722A5 JP 2002521433 A JP2002521433 A JP 2002521433A JP 2002521433 A JP2002521433 A JP 2002521433A JP 2004506722 A5 JP2004506722 A5 JP 2004506722A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
ethoxy
oxazol
propionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002521433A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004506722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/022617 external-priority patent/WO2002016332A1/en
Publication of JP2004506722A publication Critical patent/JP2004506722A/ja
Publication of JP2004506722A5 publication Critical patent/JP2004506722A5/ja
Withdrawn legal-status Critical Current

Links

JP2002521433A 2000-08-23 2001-08-23 ペルオキシソーム増殖因子活性化受容体の調節方法 Withdrawn JP2004506722A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22745600P 2000-08-23 2000-08-23
PCT/US2001/022617 WO2002016332A1 (en) 2000-08-23 2001-08-23 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists

Publications (2)

Publication Number Publication Date
JP2004506722A JP2004506722A (ja) 2004-03-04
JP2004506722A5 true JP2004506722A5 (enExample) 2008-10-09

Family

ID=22853183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002521433A Withdrawn JP2004506722A (ja) 2000-08-23 2001-08-23 ペルオキシソーム増殖因子活性化受容体の調節方法

Country Status (10)

Country Link
US (1) US7176224B2 (enExample)
EP (1) EP1313717B1 (enExample)
JP (1) JP2004506722A (enExample)
AT (1) ATE375985T1 (enExample)
AU (1) AU2001284660A1 (enExample)
CA (1) CA2418134A1 (enExample)
DE (1) DE60131001T2 (enExample)
ES (1) ES2295200T3 (enExample)
MX (1) MXPA03001610A (enExample)
WO (1) WO2002016332A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2418104A1 (en) * 2000-08-23 2002-02-28 Eli Lilly And Company Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
DE60129712T2 (de) 2000-08-23 2008-07-03 Eli Lilly And Co., Indianapolis Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten
NZ529351A (en) * 2001-06-07 2006-01-27 Lilly Co Eli Modulators of peroxisome proliferator activated receptors
EA200400011A1 (ru) 2001-06-07 2004-06-24 Эли Лилли Энд Компани Модуляторы рецепторов, активируемых пролифераторами пероксисом (prar)
JP4276074B2 (ja) * 2001-10-12 2009-06-10 日本ケミファ株式会社 ペルオキシソーム増殖剤応答性受容体δの活性化剤
US20050080115A1 (en) * 2002-10-28 2005-04-14 Lone Jeppesen Novel compounds, their preparation and use
ES2295692T3 (es) * 2002-11-08 2008-04-16 F. Hoffmann-La Roche Ag Nuevos derivados de 4-alcoxioxazol sustituido como agonistas de ppar.
US7192970B2 (en) * 2002-11-26 2007-03-20 Chipscreen Biosciences, Ltd. Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
CA2512883A1 (en) 2003-02-14 2004-09-02 Eli Lilly And Company Sulfonamide derivatives as ppar modulators
DE102004060227B3 (de) 2004-12-15 2006-07-20 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Oxazolen durch Kondensation von aromatischen Aldehyden mit α-Ketoximen zu N-Oxiden und nachfolgende Reaktion mit aktivierten Säurederivaten
EP1911738A4 (en) * 2005-07-29 2009-12-16 Takeda Pharmaceutical COMPOUND OF PHENOXYALKANOIC ACID
JP5546542B2 (ja) 2009-08-05 2014-07-09 第一三共株式会社 アミド誘導体
NZ610145A (en) * 2010-10-14 2015-02-27 Daiichi Sankyo Co Ltd Acylbenzene derivative having a hypoglycemic action and/or a β cell- or pancreas-protecting action

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
US5232945A (en) * 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
DE69723680T9 (de) 1996-02-02 2004-11-04 Merck & Co., Inc. Antidiabetische mittel
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
IL128600A0 (en) 1996-08-19 2000-01-31 Japan Tobacco Inc Propionic acid derivatives and pharmaceutical compositions containing them
JP4345230B2 (ja) * 1998-03-10 2009-10-14 小野薬品工業株式会社 カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤
DK1206457T3 (da) 1999-08-27 2004-02-16 Lilly Co Eli Biaryl-oxa(thia)zolderivater og deres anvendelse som modulatorer PPAP'ER
JP4316787B2 (ja) 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、
CA2418104A1 (en) 2000-08-23 2002-02-28 Eli Lilly And Company Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
DE60129712T2 (de) 2000-08-23 2008-07-03 Eli Lilly And Co., Indianapolis Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten

Similar Documents

Publication Publication Date Title
JP2009519965A5 (enExample)
JP2004534824A5 (enExample)
JP2013519680A5 (enExample)
JP2004529174A5 (enExample)
JP2007511485A5 (enExample)
JP2004506721A5 (enExample)
JP2004534035A5 (enExample)
JP2021511360A5 (enExample)
HRP20160450T1 (hr) Novi inhibitori reduktaze s-nitrozoglutationa
US20140039009A1 (en) Compounds for inflammation and immune-related uses
JP2005528348A5 (enExample)
JP2019517455A5 (enExample)
JP2014510132A5 (enExample)
JP2007520471A5 (enExample)
JP2007505916A5 (enExample)
JP2010513397A5 (enExample)
JP2009520769A5 (enExample)
CA2565813A1 (en) Substituted methyl aryl or heteroaryl amide compounds
JP2008507532A5 (enExample)
JP2005539088A5 (enExample)
JP2003528918A5 (enExample)
JP2008526866A5 (enExample)
JP2005526081A5 (ja) 代謝型グルタメート受容体−5の二アリール置換テトラゾールモジュレータ
JP2007523181A5 (enExample)
JP2009540009A5 (enExample)